141 related articles for article (PubMed ID: 25084748)
1. Altered platelet calsequestrin abundance, Na⁺/Ca²⁺ exchange and Ca²⁺ signaling responses with the progression of diabetes mellitus.
Zheng Y; Wang L; Zhu Z; Yan X; Zhang L; Xu P; Luo D
Thromb Res; 2014 Sep; 134(3):674-81. PubMed ID: 25084748
[TBL] [Abstract][Full Text] [Related]
2. Potential regulatory role of calsequestrin in platelet Ca(2+) homeostasis and its association with platelet hyperactivity in diabetes mellitus.
Zhu Z; Zhou H; Yu X; Chen L; Zhang H; Ren S; Wu Y; Luo D
J Thromb Haemost; 2012 Jan; 10(1):116-24. PubMed ID: 22060633
[TBL] [Abstract][Full Text] [Related]
3. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
Judge S; Mammen E; Dunbar JC
J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
[TBL] [Abstract][Full Text] [Related]
4. Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus.
Li Y; Woo V; Bose R
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1480-9. PubMed ID: 11247757
[TBL] [Abstract][Full Text] [Related]
5. Conventional protein kinase C isoforms differentially regulate ADP- and thrombin-evoked Ca²⁺ signalling in human platelets.
Lever RA; Hussain A; Sun BB; Sage SO; Harper AG
Cell Calcium; 2015 Dec; 58(6):577-88. PubMed ID: 26434503
[TBL] [Abstract][Full Text] [Related]
6. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding.
Winocour PD; Perry DW; Kinlough-Rathbone RL
Eur J Clin Invest; 1992 Jan; 22(1):19-23. PubMed ID: 1559539
[TBL] [Abstract][Full Text] [Related]
8. Ca2+ leakage rate from agonist-sensitive intracellular pools is altered in platelets from patients with type 2 diabetes.
Zbidi H; Jardin I; Bartegi A; Salido GM; Rosado JA
Platelets; 2011; 22(4):284-93. PubMed ID: 21526890
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aggregation of rabbit and human platelets induced by adrenaline and 5-hydroxytryptamine by KB-R7943, a Na(+)/Ca(2+) exchange inhibitor.
Takano S; Kimura J; Ono T
Br J Pharmacol; 2001 Apr; 132(7):1383-8. PubMed ID: 11264230
[TBL] [Abstract][Full Text] [Related]
10. Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production.
Schaeffer G; Wascher TC; Kostner GM; Graier WF
Diabetologia; 1999 Feb; 42(2):167-76. PubMed ID: 10064096
[TBL] [Abstract][Full Text] [Related]
11. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
13. Long-term untreated streptozotocin-diabetes leads to increased expression and elevated activity of prostaglandin H2 synthase in blood platelets.
Siewiera K; Kassassir H; Talar M; Wieteska L; Watala C
Platelets; 2016; 27(3):203-11. PubMed ID: 26325148
[TBL] [Abstract][Full Text] [Related]
14. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation and disaggregation in the streptozotocin induced diabetic rat: the effect of sympathetic inhibition.
Dunbar JC; Reinholt L; Henry RL; Mammen E
Diabetes Res Clin Pract; 1990 Jul; 9(3):265-72. PubMed ID: 2146102
[TBL] [Abstract][Full Text] [Related]
16. Increased platelet aggregation and fatty acid oxidation in diabetic rats.
Iida N; Iida R; Takeyama N; Tanaka T
Biochem Mol Biol Int; 1993 May; 30(1):177-85. PubMed ID: 8358330
[TBL] [Abstract][Full Text] [Related]
17. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
Jones S; Evans RJ; Mahaut-Smith MP
Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
[TBL] [Abstract][Full Text] [Related]
18. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
[TBL] [Abstract][Full Text] [Related]
19. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
20. The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats.
Flierl U; Schöpp C; Jaitner J; Bauersachs J; Schäfer A
Thromb Res; 2010 Mar; 125(3):e93-9. PubMed ID: 19846210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
